Profluent Bio
PrivateLast Round
Series B
Nov 19, 2025
Est. Valuation
$1B
Total Funding Raised
$150M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Profluent Bio operates in Healthcare & Life Sciences and is based in Emeryville, California. Its latest recorded funding round was a Series B round in November 2025.
Profluent Bio is a biotechnology company that develops artificial intelligence-based models to design and validate novel, functional proteins for human health and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Profluent Bio Comparables
Compare Profluent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 88% | |
| Generate Biomedicines | 86% | |
| Chan Zuckerberg Biohub | 85% |
For institutional investors. Book with your work email.
Profluent Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 19, 2025 | ||||
| Series A | Mar 21, 2024 | ||||
| Seed | Jan 26, 2023 |
For institutional investors. Book with your work email.
Profluent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Phoenix Venture Partners | Seed |
| Air Street Capital | Seed, Series A, Series B |
| Bezos Expeditions | Series B |
| Convergent Ventures | Seed |
| Spark Capital | Series B, Series A |
| AIX Ventures | Seed |
| Insight Partners | Series A, Series B, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2026
Grew 23% QoQ, from 69 to 85 employees.
- Aug 1, 2026
Grew 17% QoQ, from 64 to 75 employees.
For institutional investors. Book with your work email.
Profluent Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Profluent Bio's valuation, stock price, and market status.
Is Profluent Bio a public or private company?
Profluent Bio is a private company.
What is the current stock price of Profluent Bio?
Profluent Bio is a private company, so its shares have no public market price. Caplight tracks Profluent Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Profluent Bio worth (valuation)?
Profluent Bio's valuation is estimated at $1.0B based on funding round data.
Can I buy Profluent Bio stock?
Profluent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Profluent Bio's last funding round?
Profluent Bio's most recent funding round was Series B on November 19, 2025.
Who are the main investors in Profluent Bio?
Key investors in Profluent Bio include Bezos Expeditions, Spark Capital, Insight Partners, Altimeter Capital Management.
Will Profluent Bio IPO soon?
No public IPO plans have been announced for Profluent Bio.
How can I track Profluent Bio secondary market activity?
Caplight tracks bids, offers, and trades in Profluent Bio's shares on secondary markets.